Your health in your hands
You control your medical information and have it in your hand.
You manage your day to day health.
You participate in medical progress by sharing your health information and get rewarded for it.
As a result, you are getting highly personalized therapies and care tools in the setting of your choice, and cost less to the system.
We are dedicated to innovation in digital health and drug discovery.
We provide strategic guidance, governance and seed capital.
- Leads or participates in the developments of new companies, including Genelpis and Atiaspharma
- Role : Executive Chairman / CEO / Board Member
Board Memberships for LBO France
Selected past board memberships
- Either directly in private companies or via partnerhips
current investments include
Philippe Chambon Md Phd is the Managing Director of eHealth2030/eSante2030. He is also Venture Partner since early 2018 with the Digital Health team of LBOFrance, a French Private equity firm. He is also the President of Genelpis, a gene therapy start-up based in Paris. For the prior 22 years, Philippe was doing Venture Capital investments in healthcare in the US; first with The Sprout Group, a diversified venture firm, and then with New Leaf Venture Partners, a dedicated healthcare venture firm. He led the creation of New Leaf Venture Partners from the Sprout group in 2015. Over his career, he has raised over $1 billion and invested in companies at all stage of growth from start-up to public companies and small buy-outs in Healthcare Information Technologies and Life Sciences. He earned and MDPhD from University of Paris V and an MBA from Columbia University.